Multiple and clustered eruptive epidermoid cysts following treatment with topical imiquimod

Dermatology

Volumn 215, Issue 4, 2007, Pages 352-353

  Nasca, Maria Rita ^a   De Pasquale, Rocco ^a   Micali, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Basal cell carcinoma; Epidermoid cysts; Side effects, imiquimod; Topical imiquimod; Tretinoin

Indexed keywords

IMIQUIMOD; RETINOIC ACID; RETINOID;

ADULT; AGED; ANAMNESIS; ARTICLE; BASAL CELL CARCINOMA; CANCER LOCALIZATION; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; CLUSTER ANALYSIS; DISEASE COURSE; DISEASE DURATION; EPIDERMOID CYST; ERYTHEMA; FEMALE; HISTIOCYTE; HUMAN; HUMAN TISSUE; NOSE CARCINOMA; PHOTODYNAMIC THERAPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT DURATION; TREATMENT OUTCOME;

AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BIOPSY; CARCINOMA, BASAL CELL; DIAGNOSIS, DIFFERENTIAL; EPIDERMAL CYST; FACIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NOSE;

EID: 34948832669     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107630     Document Type: Article

References (13)

1. Chang YC, Madkan V, Cook-Norris R, Sra K, Tyring S: Current and potential uses of imiquimod. South Med J 2005;98:914-920.
2. Yan J, Chen SL, Wang HN, Wu TX: Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata. Dermatology 2006;213:218-223.
3. Weber A, Maurer M: Skin site mast cell numbers correlate with rates of nodular growth, but not incidence, of basal cell carcinoma. Dermatology 2005;211:298-299.
4. Brown T, Zirvi M, Cotsarelis G, Gelfand JM: Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts. J Am Acad Dermatol 2005;52:715-716.
5. Gilliet M, Conrad C, Geiges M, Cozzio A, Thurlimann W, Burg G, Nestle FO, Dummer R: Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 2004;140:1490-1495.
6. Mashiah J, Brenner S: Possible mechanisms in the induction of pemphigus foliaceus by topical imiquimod treatment. Arch Dermatol 2005;141:908-909.
7. Zalaudek I, Petrillo G, Argenziano G: Aphthous ulcers and imiquimod. J Am Acad Dermatol 2005;53:360-361.
8. Barton JC: Angioedema associated with imiquimod. J Am Acad Dermatol 2004;51:477-478.
9. Yi BA, Nirenberg MJ, Goldstein SM, Berger TG: Chronic neuropathic pain associated with imiquimod: report of 2 cases. J Am Acad Dermatol 2005;52:57-58.
10. Benson E: Imiquimod: potential risk of an immunostimulant. Australas J Dermatol 2004;45:123-124.
11. Ghaffar SA, Clements SE, Lear JT: Epidermoid cysts mimicking recurrence of superficial basal cell carcinoma following photodynamic therapy. Clin Exp Dermatol 2006;32:223-224.
12. Stefanidou MP, Panayotides JG, Tosca AD: Milia en plaque: a case report and review of the literature. Dermatol Surg 2002;28:291-295.
13. Marty CL, Randle HW, Walsh JS: Eruptive epidermoid cysts resulting from treatment with imiquimod. Dermatol Surg 2005;31:780-782.